{"url":"https://lda.senate.gov/api/v1/filings/b553d3f6-1f84-488e-b66f-eab32e2104f7/","filing_uuid":"b553d3f6-1f84-488e-b66f-eab32e2104f7","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/b553d3f6-1f84-488e-b66f-eab32e2104f7/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Mike Nielsen","dt_posted":"2026-04-17T23:03:43-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1307 New York Ave., NW Suite 600","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":76992,"url":"https://lda.senate.gov/api/v1/registrants/76992/","house_registrant_id":36118,"name":"CGCN GROUP, LLC","description":"Public Affairs Consultants","address_1":"1307 New York Ave., NW Suite 600","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"STEVE CLARK","contact_telephone":"+1 202-628-0028","dt_updated":"2026-07-12T16:09:24.002258-04:00"},"client":{"id":65797,"url":"https://lda.senate.gov/api/v1/clients/65797/","client_id":65797,"name":"ALVOGEN, INC.","general_description":"Pharmaceuticals company","client_government_entity":null,"client_self_select":false,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-03-31"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to domestic manufacturing and on-shoring pharmaceuticals.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142906,"prefix":null,"prefix_display":null,"first_name":"JILL","nickname":null,"middle_name":null,"last_name":"HAMAKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143752,"prefix":"mrs","prefix_display":"MRS.","first_name":"MARTHA","nickname":null,"middle_name":"BEATRICE","last_name":"MILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}